A detailed history of Lyell Wealth Management, LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Lyell Wealth Management, LP holds 2,754 shares of NVO stock, worth $317,040. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,754
Previous 2,754 -0.0%
Holding current value
$317,040
Previous $353,000 11.33%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$87.78 - $105.45 $17,556 - $21,090
200 Added 7.83%
2,754 $284,000
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $116,130 - $254,812
1,277 Added 100.0%
2,554 $232,000
Q1 2023

May 03, 2023

BUY
$132.34 - $159.14 $168,998 - $203,221
1,277 New
1,277 $203,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lyell Wealth Management, LP Portfolio

Follow Lyell Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lyell Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lyell Wealth Management, LP with notifications on news.